ABOUT 4F-MDMB K2 INFUSED PAPER

(b) If The chief commissioner establishes a program below this subchapter, the commissioner shall publish a report not later than January one of every odd-numbered 12 months over the medical effectiveness of the usage of tetrahydrocannabinols as well as their derivatives and another professional medical findings from the study application.(e) The c